November 12, 2019

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Gregory Dundas

 

Re:                             NextCure, Inc.

Registration Statement on Form S-1 (File No. 333-234639)

Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the Registration Statement.

 

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 5:00 p.m. Eastern Time, on Thursday, November 14, 2019 or as soon thereafter as practicable.

 

[Signature page follows]

 


 

Very truly yours,

 

 

 

 

 

MORGAN STANLEY & CO. LLC

 

BOFA SECURITIES, INC.

 

PIPER JAFFRAY & CO.

 

 

 

As representatives of the Underwriters

 

 

 

MORGAN STANLEY & CO. LLC

 

 

 

 

 

By:

/s/ Chris Rigoli

 

 

Name:

Chris Rigoli

 

 

Title:

Vice President

 

 

 

 

 

 

BOFA SECURITIES, INC.

 

 

 

 

 

 

By:

/s/ Greg Butz

 

 

Name:

Greg Butz

 

 

Title:

Managing Director

 

 

 

 

 

 

 

PIPER JAFFRAY & CO.

 

 

 

 

 

 

By:

/s/ Chad Huber

 

 

Name:

Chad Huber

 

 

Title:

Managing Director

 

 

[Signature Page to NextCure, Inc. Acceleration Request]